India's First mRNA Vaccine
  • Home
  • WHO WE ARE
    • GENNOVA BIO
    • OUR STRENGTHS
  • ABOUT GEMCOVAC
    • STORY OF mRNA VACCINES
    • TECHNICAL DETAILS
  • FAQs
    • PRESS
    • DOCTORS
    • GENERAL
  • MEDIA
    • PRESS COVERAGE
  • CONTACT US
    • SALES
    • HEALTHCARE PROFESSIONALS
    • HOSPITAL/INSTITUTION
    • MEDIA AND PRESS
  • More
    • Home
    • WHO WE ARE
      • GENNOVA BIO
      • OUR STRENGTHS
    • ABOUT GEMCOVAC
      • STORY OF mRNA VACCINES
      • TECHNICAL DETAILS
    • FAQs
      • PRESS
      • DOCTORS
      • GENERAL
    • MEDIA
      • PRESS COVERAGE
    • CONTACT US
      • SALES
      • HEALTHCARE PROFESSIONALS
      • HOSPITAL/INSTITUTION
      • MEDIA AND PRESS
India's First mRNA Vaccine
  • Home
  • WHO WE ARE
    • GENNOVA BIO
    • OUR STRENGTHS
  • ABOUT GEMCOVAC
    • STORY OF mRNA VACCINES
    • TECHNICAL DETAILS
  • FAQs
    • PRESS
    • DOCTORS
    • GENERAL
  • MEDIA
    • PRESS COVERAGE
  • CONTACT US
    • SALES
    • HEALTHCARE PROFESSIONALS
    • HOSPITAL/INSTITUTION
    • MEDIA AND PRESS
https://i.vimeocdn.com/video/1115432997-6644ee55f947906578d2e904078ef78f23a3d2dfbe64ec65fea36233c8c0847b-d

GEMCOVAC®-19

GEMCOVAC®-19GEMCOVAC®-19GEMCOVAC®-19

Gennova’s mRNA vaccine, GEMCOVAC®-19, which is stable at 2-8°C, 

has received the Emergency Use Authorization (EUA)

Features

India's First mRNA Vaccine

SYNTHETIC & STABLE AT 2-8˚C

India's First mRNA Vaccine

Developed to address the problems in the earlier approved mRNA vaccines.

RAPID DEVELOPMENT

SYNTHETIC & STABLE AT 2-8˚C

India's First mRNA Vaccine

The mRNA development platform has the potential to develop rapidly.

SYNTHETIC & STABLE AT 2-8˚C

SYNTHETIC & STABLE AT 2-8˚C

SYNTHETIC & STABLE AT 2-8˚C

GEMCOVAC® mRNA vaccine is stable at 2–8 °C and can be considered superior in terms of deployability in India and other developing nations (especially LMICs) compared to other approved mRNA vaccines.

1. GEMCOVAC™-19 - SmPC (pdf)Download
2. GEMCOVAC™-19 - Fact Sheet (pdf)Download
3. GEMCOVAC™-19 - Package Insert (pdf)Download

Gennova Biopharmaceuticals Limited

CIN – U24231PN2001PLC016253
T-184, MIDC, Bhosari, Pune – 411 026,
Maharashtra, India.


R&D Address:

BTS – 2 Building, Chrysalis Enclave, Block – 2, Plot -2,
TCG International Biotech Park,
Phase II, MIDC, Hinjawadi, Pune – 411 057,
Maharashtra – India


Manufacturing Address:

Block -1, Plot P1 & P2, ITBT Park, Phase II, MIDC, 

Hinjawadi, Pune – 411 057, Maharashtra, India.

Copyright © 2023 Gennova Biopharmaceuticals Limited - All Rights Reserved.

  • Privacy Policy
  • Terms and Conditions

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept